Application of diffusion-weighted whole-body MRI for response monitoring in multiple myeloma after chemotherapy: a systematic review and meta-analysis.
Kaiwen WangElsa LeeShedrack KenisSimon HallamAthar HaroonSimon WanNeil RabinAntonio Rojas-GarciaAnwar PadhaniSola AdelekePublished in: European radiology (2022)
• In multiple myeloma patients who received chemotherapy, responders have a significant absolute increase in ADC values that is not seen in non-responders. • A 35% increase in ADC from baseline values is found to classify response post-induction chemotherapy which corroborates with expert opinion from the Myeloma Response Assessment and Diagnosis System. • More evidence is needed to further characterise ADC changes by lesion subtypes over time after induction of therapy.